Market Closed –
|
5-day change | 1st Jan Change | ||
103.54 USD |
+0.71% | +0.99% | +0.10% |
Published on 05/30/2025 at 16:19

© Reuters – 2025
AFLAC Inc Files For Offering Of ¥35 Billion 1.726% Senior Notes Due 2030, ¥23.4 Billion 2.003% Senior Notes Due 2032 -SEC Filing |
04:19pm |
RE |
Raymond James Adjusts Price Target on Aflac to $110 From $115, Maintains Outperform Rating |
May. 29 |
MT |
Autonomous Research Adjusts Price Target on Aflac to $93 From $92 |
May. 27 |
MT |
Aflac Insider Sold Shares Worth $3,906,941, According to a Recent SEC Filing |
May. 22 |
MT |
BMO Capital Adjusts Price Target on Aflac to $106 From $104, Maintains Market Perform Rating |
May. 20 |
MT |
Aflac Insider Sold Shares Worth $290,689, According to a Recent SEC Filing |
May. 19 |
MT |
Morgan Stanley Adjusts Price Target on Aflac to $105 From $100, Maintains Equalweight Rating |
May. 19 |
MT |
Keefe, Bruyette & Woods Adjusts Price Target on Aflac to $106 From $104, Maintains Market Perform Rating |
May. 07 |
MT |
Aflac Incorporated Expands Partnership with Empathy to Offer Enhanced Legacy Planning Services with LifeVault |
May. 06 |
CI |
Wells Fargo Adjusts Price Target on Aflac to $103 From $102, Maintains Equalweight Rating |
May. 06 |
MT |
Piper Sandler Adjusts Price Target on Aflac to $120 From $124 |
May. 02 |
MT |
Barclays Adjusts Price Target on Aflac to $96 From $95 |
May. 01 |
MT |
Aflac Incorporated, Q1 2025 Earnings Call, May 01, 2025 |
May. 01 |
|
Aflac misses quarterly profit estimates on Japan unit weakness |
Apr. 30 |
RE |
Tranche Update on Aflac Incorporated’s Equity Buyback Plan announced on August 8, 2017. |
Apr. 30 |
CI |
Earnings Flash (AFL) AFLAC INCORPORATED Reports Q1 Adjusted EPS $1.66, vs. FactSet Est of $1.67 |
Apr. 30 |
MT |
Earnings Flash (AFL) AFLAC INCORPORATED Posts Q1 Revenue $3.4B, vs. FactSet Est of $4.26B |
Apr. 30 |
MT |
Aflac Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025 |
Apr. 30 |
CI |
TD Cowen Adjusts Price Target on Aflac to $100 From $98, Maintains Hold Rating |
Apr. 16 |
MT |
BMO Capital Adjusts Aflac Price Target to $104 From $106, Maintains Market Perform Rating |
Apr. 09 |
MT |
Morgan Stanley Adjusts Aflac Price Target to $100 From $105, Maintains Equalweight Rating |
Apr. 09 |
MT |
JPMorgan Adjusts Price Target on Aflac to $96 From $94, Maintains Neutral Rating |
Apr. 02 |
MT |
Piper Sandler Adjusts Price Target on Aflac to $124 From $118, Maintains Overweight Rating |
Apr. 02 |
MT |
UBS Adjusts Aflac Price Target to $114 From $109, Maintains Neutral Rating |
Apr. 02 |
MT |
Autonomous Adjusts Price Target on Aflac to $91 From $90 |
Mar. 03 |
MT |
AFL: Dynamic Chart
Aflac Incorporated is a life insurance group organized around 3 sectors of activity:
– sale of health and life insurance products in Japan (55.5% of net sales): including cancer life plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities;
– sale of health and life insurance products in the United States (38.7%): including accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, and long-term care plans;
– other (5.8%).
More about the company

Buy
Last Close Price
102.81USD
Average target price
105.62USD
Spread / Average Target
+2.73%
Consensus
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions